Latest Capital Raises News

Jayride Group reports a sharp decline in bookings amid supplier payment challenges but eyes growth through API technology and cost cuts.

Variscan Mines has announced a transformative update to its Novales-Udías Project, tripling its zinc-lead Mineral Resource Estimate and raising over $2 million to advance development. Drilling is underway with a Mine Re-Start Study on track for mid-2025.

Cavalier Resources has successfully raised A$1.735 million through a rights issue, positioning the company to advance its Crawford Gold Project amid record gold prices and promising exploration results.

Ragnar Metals advances its Swedish exploration with a significant spodumene pegmatite discovery at Orrvik and promising uranium assays at multiple new projects, while strengthening its strategic position through a key investment in Kaiser Reef.

Wellnex Life Limited reported a 36% rise in Q2 FY25 cash receipts and record monthly sales, while advancing its dual listing on the London Stock Exchange and expanding into the UK market.

Alchemy Resources Limited reported a slight $15,000 cash outflow in its December 2024 quarter, maintaining a solid cash balance of $2 million as it continues to invest in exploration activities.

Provaris Energy has achieved a major breakthrough with a term sheet for green hydrogen supply to Uniper, marking Europe's first large-scale regional hydrogen marine transport project. Concurrently, the company is advancing innovative CO2 tank designs in partnership with Yinson, positioning itself at the forefront of energy transition infrastructure.

Eagle Mountain Mining has strengthened its Silver Mountain copper project prospects, initiated tailings repurposing at Wedgetail, and launched a capital raise to reduce debt, while relinquishing Oracle Ridge mineral rights due to unaligned landowner terms.

Pure Resources Limited has made significant strides in its Reedy Creek Garnet Project, expanding the resource and delivering promising metallurgical test results that highlight the project's commercial potential.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.

Sultan Resources reports steady progress in its Western Australia gold and Canadian lithium projects while pausing nickel drilling due to market conditions, supported by a recent capital raise.

WIN Metals reports robust drilling results at its Butchers Creek and Golden Crown projects, confirming significant resource growth potential, alongside completing a key acquisition and securing fresh capital.